BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 27223121)

  • 1. Epigenetic regulation of SMARCB1 By miR-206, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas.
    Sápi Z; Papp G; Szendrői M; Pápai Z; Plótár V; Krausz T; Fletcher CD
    Genes Chromosomes Cancer; 2016 Oct; 55(10):786-802. PubMed ID: 27223121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
    Rekhi B; Vogel U
    APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels.
    Papp G; Krausz T; Stricker TP; Szendrői M; Sápi Z
    Genes Chromosomes Cancer; 2014 Feb; 53(2):168-76. PubMed ID: 24327545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M
    Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncomir face of microRNA-206: A permanent miR-206 transfection study.
    Mihály D; Papp G; Mervai Z; Reszegi A; Tátrai P; Szalóki G; Sápi J; Sápi Z
    Exp Biol Med (Maywood); 2018 Aug; 243(12):1014-1023. PubMed ID: 30111166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.
    Kohashi K; Yamamoto H; Kumagai R; Yamada Y; Hotokebuchi Y; Taguchi T; Iwamoto Y; Oda Y
    Mod Pathol; 2014 Jun; 27(6):832-9. PubMed ID: 24287458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms.
    Dermawan JK; Singer S; Tap WD; Nacev BA; Chi P; Wexler LH; Ortiz MV; Gounder M; Antonescu CR
    Mod Pathol; 2022 Dec; 35(12):1900-1909. PubMed ID: 36088476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary EWSR1 gene abnormalities in SMARCB1-deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Antonescu CR
    Genes Chromosomes Cancer; 2016 Oct; 55(10):767-76. PubMed ID: 27218413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre.
    Rekhi B; Jambhekar NA
    Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft tissue myoepithelial carcinoma with rhabdoid-like features and EWSR1 rearrangement: Fine needle aspiration cytology with histologic correlation.
    Machado I; López-Soto MV; Rubio L; Navarro L; Llombart-Bosch A
    Diagn Cytopathol; 2015 May; 43(5):421-6. PubMed ID: 25693574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.
    Le Loarer F; Zhang L; Fletcher CD; Ribeiro A; Singer S; Italiano A; Neuville A; Houlier A; Chibon F; Coindre JM; Antonescu CR
    Genes Chromosomes Cancer; 2014 Jun; 53(6):475-86. PubMed ID: 24585572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.
    Oda Y; Tsuneyoshi M
    Pathol Int; 2006 Jun; 56(6):287-95. PubMed ID: 16704491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma.
    Papp G; Changchien YC; Péterfia B; Pecsenka L; Krausz T; Stricker TP; Khoor A; Donner L; Sápi Z
    Mod Pathol; 2013 Mar; 26(3):393-403. PubMed ID: 23174932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
    Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.
    Sigauke E; Rakheja D; Maddox DL; Hladik CL; White CL; Timmons CF; Raisanen J
    Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
    Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrum.
    Yin X; Yang X; Wang S; Zhou J; Zhao M
    Ann Diagn Pathol; 2024 Feb; 68():152242. PubMed ID: 38039617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of SMARCB1/INI1 expression in pediatric chordomas correlates with upregulation of miR-671-5p and miR-193a-5p expressions.
    Malgulwar PB; Pathak P; Singh M; Kale SS; Suri V; Sarkar C; Sharma MC
    Brain Tumor Pathol; 2017 Oct; 34(4):155-159. PubMed ID: 28825187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.